Marcus & Millichap - MMI Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marcus & Millichap in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" MMI shares.
View MMI analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 1-year target prices for Marcus & Millichap's shares. Their MMI share price forecasts range from $26.00 to $26.00. On average, they expect the company's stock price to reach $26.00 in the next twelve months. This suggests that the stock has a possible downside of 24.0%.
View analysts price targets for MMI or view top-rated stocks among Wall Street analysts.

Marcus & Millichap's stock was trading at $51.46 at the start of the year. Since then, MMI stock has decreased by 33.6% and is now trading at $34.19.
View the best growth stocks for 2022 here.

Marcus & Millichap saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 885,100 shares, an increase of 10.6% from the August 31st total of 800,200 shares. Based on an average daily trading volume, of 134,600 shares, the days-to-cover ratio is presently 6.6 days. Currently, 3.6% of the company's shares are sold short.
View Marcus & Millichap's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our MMI earnings forecast.

Marcus & Millichap, Inc. (NYSE:MMI) announced its quarterly earnings data on Friday, August, 5th. The real estate investment trust reported $1.04 EPS for the quarter. The real estate investment trust earned $395.96 million during the quarter. Marcus & Millichap had a trailing twelve-month return on equity of 25.12% and a net margin of 11.07%. During the same quarter in the prior year, the business earned $0.78 EPS.

Marcus & Millichap announced a Semi-Annual dividend on Wednesday, August 3rd. Investors of record on Thursday, September 15th will be given a dividend of $0.25 per share on Thursday, October 6th. This represents a yield of 1.2%. The ex-dividend date is Wednesday, September 14th.
Read our dividend analysis for MMI.

Marcus & Millichap (NYSE:MMI) pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.45%. The dividend payout ratio is 11.85%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for MMI.

173 employees have rated Marcus & Millichap Chief Executive Officer Hessam Nadji on Glassdoor.com. Hessam Nadji has an approval rating of 81% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Marcus & Millichap investors own include CBRE Group (CBRE), Jones Lang LaSalle (JLL), HFF (HF), Bank of America (BAC), Chevron (CVX), Johnson & Johnson (JNJ), Wells Fargo & Company (WFC), ASML (ASML), Citizens Financial Group (CFG) and Cisco Systems (CSCO).

Marcus & Millichap trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMI."

Shares of MMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMI stock can currently be purchased for approximately $34.19.

Marcus & Millichap (NYSE:MMI) has a market capitalization of $1.37 billion and generates $1.30 billion in revenue each year. The real estate investment trust earns $142.47 million in net income (profit) each year or $4.22 on an earnings per share basis.

The company employs 801 workers across the globe.

Marcus & Millichap's mailing address is 23975 PARK SORRENTO SUITE 400, CALABASAS CA, 91302. The official website for the company is www.marcusmillichap.com. The real estate investment trust can be reached via phone at (818) 212-2250, via email at evelyn.infurna@icrinc.com, or via fax at 818-212-2260.